Results 221 to 230 of about 21,624 (243)

Dominant follicle-targeted nanocarriers for GH delivery to alleviate premature ovarian insufficiency. [PDF]

open access: yesMater Today Bio
Yang S   +10 more
europepmc   +1 more source

Loss of p21 does not protect against premature ovarian insufficiency caused by alkylating agents. [PDF]

open access: yesFront Endocrinol (Lausanne)
Lu X   +8 more
europepmc   +1 more source
Some of the next articles are maybe not open access.

Related searches:

Premature ovarian insufficiency

BMJ
Premature ovarian insufficiency (POI) is a cause of infertility and endocrine dysfunction in women, defined by loss of normal, predictable ovarian activity before the age of 40 years. POI is clinically characterized by amenorrhoea (primary or secondary) with raised circulating levels of follicle-stimulating hormone.
Zachary, Nash, Melanie, Davies
  +13 more sources

Premature ovarian insufficiency

Current Opinion in Endocrine and Metabolic Research, 2023
Natural menopause typically occurs between the ages of 46 to 55 years. Premature ovarian insufficiency or premature menopause refers to compromised ovarian follicular activity, occurring spontaneously or because of medical interventions, prior to the age of 40 years.
Svetlana Vujovic   +4 more
  +6 more sources

Premature ovarian insufficiency and infertility

Australian Journal of General Practice, 2023
Premature ovarian insufficiency (POI) is the loss of ovarian function before the age of 40 years and can be spontaneous or iatrogenic. It is an important cause of infertility, and the diagnosis should be considered in any woman presenting with oligo/amenorrhoea, even in the absence of menopausal symptoms suchas hot flushes.The aim of this article is to
Waduge, Dhanushi Fernando   +2 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy